Repository logo
 

Calicivirus VP2 forms a portal-like assembly following receptor engagement.

Accepted version
Peer-reviewed

Type

Article

Change log

Authors

Conley, Michaela J 
McElwee, Marion 
Azmi, Liyana 
Gabrielsen, Mads 
Byron, Olwyn 

Abstract

To initiate infection, many viruses enter their host cells by triggering endocytosis following receptor engagement. However, the mechanisms by which non-enveloped viruses escape the endosome are poorly understood. Here we present near-atomic-resolution cryo-electron microscopy structures for feline calicivirus both undecorated and labelled with a soluble fragment of its cellular receptor, feline junctional adhesion molecule A. We show that VP2, a minor capsid protein encoded by all caliciviruses1,2, forms a large portal-like assembly at a unique three-fold axis of symmetry, following receptor engagement. This assembly-which was not detected in undecorated virions-is formed of twelve copies of VP2, arranged with their hydrophobic N termini pointing away from the virion surface. Local rearrangement at the portal site leads to the opening of a pore in the capsid shell. We hypothesize that the portal-like assembly functions as a channel for the delivery of the calicivirus genome, through the endosomal membrane, into the cytoplasm of a host cell, thereby initiating infection. VP2 was previously known to be critical for the production of infectious virus3; our findings provide insights into its structure and function that advance our understanding of the Caliciviridae.

Description

Keywords

Animals, Calicivirus, Feline, Capsid Proteins, Cats, Cell Line, Cryoelectron Microscopy, Endosomes, Genome, Viral, Hydrophobic and Hydrophilic Interactions, Junctional Adhesion Molecule A, Models, Molecular, Receptors, Virus, Static Electricity, Virion, Virus Assembly

Journal Title

Nature

Conference Name

Journal ISSN

0028-0836
1476-4687

Volume Title

565

Publisher

Springer Science and Business Media LLC
Sponsorship
Wellcome Trust (207498/Z/17/Z)
Wellcome Trust (207498/Z/17/Z)
IG is a Wellcome Senior Fellow (Ref: 207498/Z/17/Z). M.J.C. was supported by a PhD studentship from the UK Biotechnology and Biological Sciences Research Council (BBSRC WestBIO DTP: BB/J013854/1). D.B and M.M. are supported by the UK Medical Research Council (MC_UU_12014/7).